Stay updated with breaking news from Vikas Oswal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval of Delamanid for children under 5 in India signifies a major leap in paediatric TB treatment, replacing injectables with severe side effects.
India News: Delamanid approval for under 5 children in India in March revolutionizes paediatric TB treatment, eliminating painful injectables. Central TB Division
Tuberculosis is a bacterial infection that usually affects the lungs. While it primarily impacts adults, children can also contract TB. Know all about the dangerous disease in kids.
Docs say they are recommended only for patients with high-risk respiratory conditions, everyone should mask up while stepping out
Experts emphasize the importance of incorporating the BPaL regimen into the national tuberculosis control program. It provides a shorter treatment duration and better adherence, especially for drug-resistant tuberculosis, offering hope for improved outcomes. The BPaL regimen consists of Bedaquiline, Pretomanid, and Linezolid.